PulmoScreen: A Novel Exhaled Breath Condensate Device

Craig Clements, Amie Wilkinson, Kavit Shah, Sterghios Moschos

Research output: Contribution to conferencePoster

94 Downloads (Pure)


Exhaled breath condensate (EBC) carries abundant information on airway health and disease, as well as systemic disease. Current EBC samplers focus on volatile compounds and protein biomarkers. This approach does not allow for analysis of biomolecules (e.g. DNA, proteins, metabolites). We are developing an optimised EBC biomolecule sampler and analyser using EBC microbiomics (infectious disease) as a validation approach.
Original languageEnglish
Publication statusPublished - 22 Nov 2018
EventMolecular Diagnostics World Summit 2018 - Hilton London Olympia Hotel, London, United Kingdom
Duration: 22 Nov 201823 Nov 2018


ConferenceMolecular Diagnostics World Summit 2018
Abbreviated titleMOLRDIAX 2018
Country/TerritoryUnited Kingdom
Internet address


Dive into the research topics of 'PulmoScreen: A Novel Exhaled Breath Condensate Device'. Together they form a unique fingerprint.

Cite this